Human NK cell-mediated cytotoxicity triggered by CD86 and Galα1,3-Gal is inhibited in genetically modified porcine cells

Journal of Immunology

Volumn 168, Issue 8, 2002, Pages 3808-3816

  Costa, Cristina ^a   Barber, Domingo F ^a   Fodor, William L ^a  

^a ALEXION PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CD59 ANTIGEN; CD86 ANTIGEN; GALACTOSYL ALPHA 1,3 GALACTOSE; TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CYTOLYSIS; DNA MODIFICATION; ENDOTHELIUM CELL; FIBROBLAST; GRAFT REJECTION; GRAFT SURVIVAL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

EID: 0037090335     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.8.3808     Document Type: Article

References (59)

1. Xenogeneic transplantation
2. Xenotransplantation
3. Discordant organ xenotransplantation in primates
4. Xenogeneic cell therapy: Current progress and future developments in porcine cell transplantation
5. Mechanism of complement activation in the hyperacute rejection of porcine organs in primate recipients
6. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy
7. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection
8. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model
9. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs
10. Transgenic pigs expressing human CD59 and decay accelerating factor produce an intrinsic barrier to complement-mediated damage
11. Mechanisms of delayed xenograft rejection
12. Acute vascular rejection
13. The role of Abs in acute vascular rejection of pig-to-baboon cardiac transplants
14. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection
15. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses
16. Natural killer cell- and macrophage-mediated discordant guinea pig-rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity
17. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period
18. Molecular mechanisms in cell-mediated cytotoxicity
19. Natural killer cells: From no receptors to too many
20. Killer inhibitory receptors: Diversity, specificity, and function
21. On guard: Activating NK cell receptors
22. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
23. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
24. NK cell triggering by human costimulatory molecules CD80 and CD86
25. Expression of a variant of CD28 on a subpopulation of human NK cells: Implications for B7-mediated stimulation of NK cells
26. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
27. Human natural killer cells account for non-MHC class I-restricted cytolysis of porcine cells
28. Circulating human mononuclear cells exhibit augmented lysis of pig endothelium after activation with interleukin 2
29. Induction of swine major histocompatibility complex class I molecules on porcine endothelium by tumor necrosis factor-α reduces lysis by human natural killer cells
30. Target cell susceptibility to lysis by human natural killer cells is augmented by α(1,3)-galactosyltransferase and reduced by α(1,2)-fucosyltransferase
31. α-Gal-independent dual recognition and activation of xenogeneic endothelial cells and human naive natural killer cells
32. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues
33. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells
34. Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1
35. Expression by α1.2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis
36. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human Ab binding and complement-mediated cytolysis
37. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
38. Transduction of genes using retrovirus vectors
39. An α-D-galactosyl-binding lectin from Bandeiraea simplicifolia seeds
40. Purification and characterization of an antiH(O) phytohemagglutinin of Ulex europeus
41. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells
42. Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT
43. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244)
44. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line
45. Up-regulation of B7 molecules by Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line
46. Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells
47. Porcine aortic endothelial cells activate human T cells: Direct presentation of swine MHC antigens and costimulation by ligands for human CD2 and CD28
48. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection
49. T cell proliferation involving the CD28 pathway is associated with cyclosporine resistant interleukin-2 gene expression
50. Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28-dependent human T cell proliferation
51. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)
52. Triggering of murine NK cells by CD40 and CD86 (B7-2)
53. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses
54. Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity
55. Turning on natural killer cells
56. Direct activation of porcine endothelial cells by natural killer cells
57. Induction of procoagulant function in porcine endothelial cells by human natural killer cells
58. Activated human NK cells can stimulate resting B cells to secrete immunoglobulin
59. Appendix I